Evaluation of patient adherence with oral anticancer agents

被引:0
|
作者
Kazaz, Seher Nazli [1 ]
Yildirim, Atila [1 ]
机构
[1] Karadeniz Tech Univ, Sch Med, Dept Med Oncol, Trabzon, Turkiye
关键词
Adherence; cancer; modified medication adherence scale-6; modified morisky scale; oral anticancer drugs; MEDICATION ADHERENCE; THERAPY; OUTCOMES; INTERVENTIONS; NONADHERENCE; MANAGEMENT; DURATION; IMATINIB;
D O I
10.4103/jcrt.jcrt_2238_22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background:The aim of the study was to measure the adherence to oral anticancer treatments in cancer patients using the Modified Morisky Scale (Modified Medication Adherence Scale 6) which has been shown to be valid and reliable in Turkish. Methods:This study was an observational, single-center study involving 300 cancer patients receiving various oral anticancer agents admitted to our outpatient clinic. Motivation and knowledge scores were calculated as per the Modified Medication Adherence Scale 6. Results:The motivation and knowledge levels of the population aged less than 65 years were found to be significantly higher than the geriatric population (>= 65 years old) (P < .003 and P< .001, respectively). It was observed that the patients with higher education levels had significantly higher motivation and knowledge levels (P < .0001 for both). There was no correlation between the motivation and knowledge levels of the patients with gender, marital status, living status, and stage of the disease (P > .05). In addition, the duration of drug use >12 months and the cyclical use of drugs were also found to be significantly associated with increased motivation and knowledge levels. Conclusion:Identifying adherence and related factors, informing patients in detail about the efficacy and toxicity of treatments are the simplest and most basic methods. Particular attention should be paid to patients aged > 65 years, patients with a low level of education, and patients in the earlier stages of their treatments.
引用
收藏
页码:1707 / 1712
页数:6
相关论文
共 50 条
  • [21] A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes
    Macintosh, P. W.
    Pond, G. R.
    Pond, B. J.
    Leung, V.
    Siu, L. L.
    EUROPEAN JOURNAL OF CANCER CARE, 2007, 16 (04) : 380 - 386
  • [22] Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence
    Dos Santos, Melanie
    Lange, M.
    Gervais, R.
    Clarisse, B.
    Capel, A.
    Barillet, M.
    Grellard, J. M.
    Heutte, N.
    Licaj, I.
    Joly, F.
    SUPPORTIVE CARE IN CANCER, 2019, 27 (09) : 3573 - 3581
  • [23] Interventions for adherence with oral chemotherapy in hematological malignancies: A systematic review
    Kavookjian, Jan
    Wittayanukorn, Saranrat
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2015, 11 (03) : 303 - 314
  • [24] Oral Agents for Cancer Treatment Effective Strategies to Assess and Enhance Medication Adherence
    Fennimore, Laura A.
    Ginex, Pamela K.
    NURSING CLINICS OF NORTH AMERICA, 2017, 52 (01) : 115 - +
  • [25] Treatment experiences and cancer experiences The patient's appropriation of the oral anticancer agents
    Marmorat, Thibaud
    Rioufol, Catherine
    Ranchon, Florence
    Caffin, Anne-Gaelle
    Preau, Marie
    SCIENCES SOCIALES ET SANTE, 2018, 36 (02): : 73 - 96
  • [26] Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study
    Nizet, Pierre
    Touchefeu, Yann
    Pecout, Solange
    Cauchin, Estelle
    Beaudouin, Eva
    Mayol, Severine
    Fronteau, Clementine
    Huon, Jean-Francois
    SUPPORTIVE CARE IN CANCER, 2022, 30 (03) : 2591 - 2604
  • [27] Adherence to oral chemotherapy: Challenges and opportunities
    Krikorian, Susan
    Pories, Susan
    Tataronis, Gary
    Caughey, Thomas
    Chervinsky, Kirsten
    Lotz, Margaret
    Shen, Abra H.
    Weissmann, Lisa
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (07) : 1590 - 1598
  • [28] Oral anticancer agent medication adherence by outpatients
    Kimura, Michio
    Usami, Eiseki
    Iwai, Mina
    Nakao, Toshiya
    Yoshimura, Tomoaki
    Mori, Hiromi
    Sugiyama, Tadashi
    Teramachi, Hitomi
    ONCOLOGY LETTERS, 2014, 8 (05) : 2318 - 2324
  • [29] Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents
    Doshi, Jalpa A.
    Li, Pengxiang
    Huo, Hairong
    Pettit, Amy R.
    Armstrong, Katrina A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05) : 476 - +
  • [30] Optimizing Adherence to Oral Anticancer Agents: Results from an Implementation Mapping Study
    Muluneh, Benyam
    Upchurch, Maurlia
    Mackler, Emily
    Bryant, Ashley Leak
    Wood, William A.
    Wheeler, Stephanie B.
    Zullig, Leah L.
    Lafata, Jennifer Elston
    CURRENT ONCOLOGY, 2025, 32 (02)